GL1X · GenesisL1 explorer

Research workbench

Golgi alpha-mannosidase II in complex with 5-substitued swainsonine analog: (5R)-5-[2'-oxo-2'-(4-METHYLPHENYL)ETHYL]-swainsonine

Analyse Golgi alpha-mannosidase II in complex with 5-substitued swainsonine analog… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3EJQ
Type
protein
Length
1,016 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-mannosidase 2
EC
3.2.1.114
UniProt
Q24451
Ligands
HN3, NAG, ZN
Pockets
13 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-mannosidase 2 (EC 3.2.1.114)protein101624% helix, 30% strandQ24451

Ligands and binding sites

  • HN3 · 1-(4-methylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • ZN · Zinc ion · metal · chains A
  • MRD · (4R)-2-methylpentane-2,4-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11310.800.9832empty
22430.770.9143empty
36230.720.7993empty
42710.630.8131empty
52410.520.7633HN3

Modifications

Observed in the structure: 5 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 3EJQ · Golgi alpha-Mannosidase II in complex with 5-substitued swainsonine analog… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.